外资机构密集调研A股公司 科技赛道成重点

Group 1 - Foreign institutional interest in A-shares remains strong as of February 9, 2026, with 224 foreign institutions conducting 569 research visits to A-share listed companies, including major firms like Morgan Stanley, BlackRock, Goldman Sachs, and Citigroup [1] - Goldman Sachs maintains a "overweight" rating on Chinese stocks, predicting a 20% increase in the China index and a 12% rise in the CSI 300 index, while UBS expects a significant rebound in the MSCI China index's earnings growth from 2.5% last year to 13.6% this year, primarily driven by technology stocks [1] - The top three companies attracting foreign research interest are Huaming Equipment, Yingshi Innovation, and Huichuan Technology, with over 20 foreign institutions also researching companies like Optoelectronics, Yihua, Anji Technology, China Resources Micro, and Sitwei, indicating a focus on sectors such as semiconductors and robotics [1] Group 2 - The Chief Investment Officer of UBS Wealth Management highlights the growth and profit potential of the Chinese market, driven by ongoing technological innovation and a favorable business environment, with sectors like healthcare, consumption, materials, and power equipment expected to benefit from trends such as healthcare companies going global and the rise of new consumption models [1] - In 2026, the Chief Investment Officer of Invesco expresses optimism for the Chinese stock market, citing improving fundamentals and long-term growth drivers that are likely to create a more sustainable structural growth cycle [2] - Key investment opportunities in the Chinese stock market include industrial upgrades in electric vehicles, pharmaceuticals, and automation, as well as the rise of artificial intelligence, with China positioned as a strong competitor in the global AI landscape due to its large internet user base, low energy costs, and abundant talent and data resources [2]